Stroke Trial, Recruiting NCT05903560 Sponsor: Jinling Hospital, China Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05903560
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had an acute stroke caused by a blocked blood vessel in the back part of the brain (posterior circulation), confirmed by symptoms and brain scans.
  • People whose stroke is caused by a blockage in a specific artery at the base of the brain (called the basilar artery), confirmed by a specialised blood vessel imaging scan.
  • People aged 18 years or older.
  • People whose stroke symptoms started no more than 24 hours before being enrolled in the trial.
  • People with a stroke severity score of 10 or higher on a standard medical scale (NIHSS) before enrolment, indicating a moderately severe to severe stroke.
  • People whose hand has normal blood supply through two separate pathways, confirmed by a simple physical test (called the modified Allen's test).
  • People (or their legally authorised representative) who are able to provide written agreement to participate.

Who may not be able to join:

  • People who already had significant disability before the stroke, based on a standard disability scale (mRS score of 3 or higher).
  • People who are pregnant or breastfeeding.
  • People who have a known allergy to contrast dye used in scans, or to a metal called nitinol used in medical devices.
  • People who are already taking part in another clinical trial.
  • People with very high blood pressure (systolic above 185 mmHg or diastolic above 110 mmHg) that cannot be brought under control with blood pressure medication.
  • People with a known condition that affects blood clotting, or who are taking blood-thinning medication with a clotting test result (INR) above 1.7.
  • People with blood test results outside safe limits, including very low or very high blood sugar, a low platelet count, or low red blood cell levels (confirm specific values with trial site).
  • People who are not expected to live longer than one year.
  • People who are unlikely to be available for follow-up appointments within 90 days, for example due to having no fixed address or living overseas.
  • People who had their stroke within 48 hours of a heart procedure, brain blood vessel procedure, or major surgery (those more than 48 hours post-procedure may still be considered).
  • People showing signs of inflammation of the blood vessels in the brain (central nervous system vasculitis).
  • People with pre-existing neurological conditions or mental health disorders that would make it difficult to assess the stroke's effects.
  • People with physical conditions or abnormalities that would make it difficult to access the arteries in the wrist or groin needed for the procedure, such as local infection, structural abnormalities, or previous surgery in those areas.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xinfeng Liu, MD, Department of Neurology, Jinling Hospital, China

Phone: +86 2584801861

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jinling Hospital, China
Registry
ClinicalTrials.gov
Start date
22 July 2023
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The proportion of favorable neurological function at 90 days (defined as mRS score ≤ 3)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov